Neuraly Inc., of Germantown, Md., raised $36 million in series A financing from South Korean holding company D&D Pharmatech, with participation by major Korean venture funds, including: Smilegate Investment, Intervest, LB Investment, Magna Investment, Geon Investment and Dongkoo Bio&Pharma.